Evidence map›Paper›PMID 38293173›Full record

ArticlebioRxiv : the preprint server for biology2025

Single-cell morphodynamical trajectories enable prediction of gene expression accompanying cell state change.

Jeremy Copperman, Ian C Mclean, Sean M Gross, Jalim Singh, Vaibhav Murthy, Young Hwan Chang, Alexander E Davies, Daniel M Zuckerman, Laura M Heiser

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Jeremy CoppermanCancer Early Detection Advanced Research Center, Oregon Health and Science University, Portland OR 97239, U.S.A.ORCID 0000-0002-5202-0690
Ian C McleanDepartment of Biomedical Engineering, Oregon Health and Science University, Portland OR 97239, U.S.A.ORCID 0000-0003-2741-7941
Sean M GrossDepartment of Biomedical Engineering, Oregon Health and Science University, Portland OR 97239, U.S.A.ORCID 0000-0002-9621-8551
Jalim SinghKnight Cancer Institute, Oregon Health and Science University, Portland OR 97239, U.S.A.ORCID 0000-0001-8027-6653
Vaibhav MurthyDepartment of Biomedical Engineering, Oregon Health and Science University, Portland OR 97239, U.S.A.ORCID 0000-0002-4171-2296
Young Hwan ChangDepartment of Biomedical Engineering, Oregon Health and Science University, Portland OR 97239, U.S.A.ORCID 0000-0001-8764-1959
Alexander E DaviesDepartment of Biomedical Engineering, Oregon Health and Science University, Portland OR 97239, U.S.A.ORCID 0000-0002-1917-8816
Daniel M ZuckermanDepartment of Biomedical Engineering, Oregon Health and Science University, Portland OR 97239, U.S.A.ORCID 0000-0001-7662-2031
Laura M HeiserDepartment of Biomedical Engineering, Oregon Health and Science University, Portland OR 97239, U.S.A.ORCID 0000-0003-3330-0950

Funding

OutreachU54HG008100 · NHGRI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GRAY, JOE W., HEISER, LAURA MADELINE · 2014 to 2019
$10.5M
Understanding the Impact of Microscale and Nanoscale Heterogeneity and ResistanceU54CA209988 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI DEMIR, EMEK, HEISER, LAURA MADELINE · 2017 to 2021
$10.3M
Omic and Multidimensional Spatial Atlas of Metastatic Breast CancerU2CCA233280 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOECKS, JEREMY · 2018 to 2023
$9.7M
Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimensU01CA224012 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI BRODY, JONATHAN, COUSSENS, LISA M. · 2019 to 2023
$2.9M
Targeting ERK-AKT-mediated single-cell drug response heterogeneity in metastatic osteosarcomaK01OD031811 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI DAVIES, ALEXANDER E · 2021 to 2025
$599k
NCI NIH HHS U01 CA224012NCI NIH HHS U2C CA233280NCI NIH HHS U54 CA209988NHGRI NIH HHS U54 HG008100NIH HHS K01 OD031811
6 · The paper itself

Abstract

Extracellular signals induce changes to molecular programs that modulate multiple cellular phenotypes, including proliferation, motility, and differentiation status. The connection between dynamically adapting phenotypic states and the molecular programs that define them is not well understood. Here we develop data-driven models of single-cell phenotypic responses to extracellular stimuli by linking gene transcription levels to "morphodynamics" - changes in cell morphology and motility observable in time-lapse image data. We adopt a dynamics-first view of cell state by grouping single-cell trajectories into states with shared morphodynamic responses. The single-cell trajectories enable development of a first-of-its-kind computational approach to map live-cell dynamics to snapshot gene transcript levels, which we term MMIST, Molecular and Morphodynamics-Integrated Single-cell Trajectories. The key conceptual advance of MMIST is that cell behavior can be quantified based on dynamically defined states and that extracellular signals change the overall distribution of cell states by altering rates of switching between states. We find a cell state landscape that is bound by epithelial and mesenchymal endpoints, with distinct sequences of epithelial to mesenchymal transition (EMT) and mesenchymal to epithelial transition (MET) intermediates. The analysis yields predictions for gene expression changes consistent with curated EMT gene sets and predicts expression of thousands of RNA transcripts through extracellular signal-induced EMT and MET with near-continuous time resolution. The MMIST framework leverages true single-cell dynamical behavior to generate molecular-level omics inferences and is broadly applicable to other biological domains, time-lapse imaging approaches and molecular snapshot data.

Identifiers

PMID38293173
PMCPMC10827140

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.